Oncovista Innovative Therapies, INC
SEC CIK 1094847 · ovit · last insider filing 2012-04-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Weis Alexander L | Director · President, CEO, CFO, Secretary | filed 2007 - 2011 |
| Ruckdaeschel Alexander | Director | filed 2007 - 2011 |
| Brock William J | Director | filed 2008 - 2011 |
| Mieyal Paul A | Director | filed 2009 - 2009 |
| Wemett James Carman | Director | filed 2007 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Moloney Michael | Chief Operating Officer | filed 2012 - 2012 |
| Edwards J Michael | Chief Financial Officer | filed 2008 - 2008 |
| Levenson Corey | Chief Technical Officer | filed 2007 - 2007 |
| Patterson Robert Bingham | Chief Financial Officer | filed 2007 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.